Global Vaporizers, E-Cigarettes, And Other Electronic Nicotine Delivery Systems (ENDS) Market Trends And Forecast Report 2022

Market
Jul.04.2022

The global vaporizers, e-cigarettes, and other electronic nicotine delivery systems (ENDS) market size is expected to grow from $19.92 billion in 2021 to $25.03 billion in 2022 at a compound annual growth rate (CAGR) of 25.6%.The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The Vaporizers, E-Cigarettes, and other ENDS market is expected to reach $55.99 billion in 2026 at a CAGR of 22.3%.

 

The Business Research Company offers the Vaporizers, E-Cigarettes, And Other Electronic Nicotine Delivery Systems (ENDS) Global Market Report 2022 in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

 

The vaporizers, e-cigarettes, and other Electronic Nicotine Delivery Systems (ENDS) market consists of sales of vaporizers, e-cigarettes, and other electronic nicotine delivery systems. These are used for inhaling the active ingredients of plant material such as tobacco, or other herbs or blends.

 

Some key vaporizers, e-cigarettes, and other electronic nicotine delivery systems (ends) market players are Dash Vapes, Hubbly Bubbly, Liquideu, Nice Vapor, Pacific Smoke International.

 

The countries covered in the global vaporizers, e-cigarettes, and other electronic nicotine delivery systems (ends) market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

 

The regions covered in the global vaporizers, e-cigarettes, and other electronic nicotine delivery systems (ends) market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 

Vaporizers, E-Cigarettes, And Other Electronic Nicotine Delivery Systems (ENDS) Market Segmentation:

By Type

1. Vaporizers

2. E-Cigarettes

3. Other Electronic Nicotine Delivery Systems (ENDS)

 

By E-Cigarettes Type

1. Disposable

2. Rechargable

3. Modular

 

By Vaporizers Type

1. E-Cigarette Vaporizers

2. Marijuana Vaporizers

3. Medical Vaporizers

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts held a UK vape duty stamp compliance exchange in Shenzhen on May 14, bringing together representatives from nearly 20 companies. The session addressed Vaping Products Duty, duty stamp applications, UK agency qualifications and warehousing, while introducing 2Firsts Compliance Solutions’ UK service.
Events
May.17
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
RLX Technology’s Q1 net revenues rose 96.2% year over year, with international business accounting for 72.3% of total revenue. Beyond the headline growth, the results point to deeper globalization: European operations, Nexus supply-chain integration and a broader product portfolio are becoming key signals to watch.
Special Report
May.20
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
The U.S. Food and Drug Administration (FDA) said its youth e-cigarette prevention campaign, “The Real Cost,” prevented about 444,000 U.S. youth from starting e-cigarette use between 2023 and 2024 and blocked more than $42 million in unauthorized e-cigarette sales that would have been used by youth.
Market
Jun.25
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18